Boehringer Ingelheim recentlyannounced a collaboration with Weill Cornell Medicine to identify new treatment approaches forchronic obstructive pulmonary disease (COPD)in order to develop novel treatments that could possibly halt or even reverse the progression of the disease process. The new, three-year collaboration combines Weill Cornell Medicines Department of Genetic Medicines unique understanding of chronic airway diseases and experience in the investigation of novel therapeutic concepts for airway repair with Boehringer Ingelheims expertise in the discovery and development of new therapies for respiratory diseases. This collaboration is the second collaboration between Boehringer Ingelheim and Weill Cornell Medicine, following prior work in inflammatory bowel disease (IBD).
Chronic lower respiratory diseases, which include COPD, are the third leading cause of death in the United States,and approximately 15million Americans have been told by a healthcare provider that they have COPD.It cannot be cured and current treatment approaches focus on bronchodilation, reducing symptoms and preventing exacerbations to decelerate the downward spiral of the disease.The goal is to help patients keep as active as possible and overall, improve their quality of life.
Our continuous search for molecular drivers of chronic obstructive airway diseases has revealed novel repair mechanisms that warrant further investigation of their potential as therapeutic approaches, said Dr. Ronald G. Crystal, Chairman of Genetic Medicine at Weill Cornell Medicine and lead investigator in the new collaboration. We will look to further expand our knowledge about progressive airway destruction in close collaboration with Boehringer Ingelheim and focus on promising therapeutic concepts with the potential to slow down or halt progressive airway damage in patients with COPD.
We are delighted to work with Dr. Crystal at Weill Cornell Medicine, who is one of the leading scientists in severe progressive airway diseases worldwide, said Dr. Clive R. Wood, Senior Corporate Vice President, Discovery Research at Boehringer Ingelheim. The scientists at Weill Cornell Medicine and Boehringer Ingelheim will work hand in hand to translate new discoveries into drug discovery and development programs at Boehringer Ingelheim. The new collaboration is an excellent example of our unique partnering approach and our focus on early innovation, underscoring our ambition to develop the next generation of medical treatments for patients with COPD.
Boehringer Ingelheim is combining a focus on cutting-edge science with a long-term view enabling the company to create a stable environment for the development of the next generation of medical breakthroughs. This new project adds another building block in this long-term strategy to improve the lives of patients with high unmet medical needs.
Weill Cornell’s Office of BioPharma Alliances and Research Collaborations negotiated the three-year collaboration.The offices mission is to proactively generate, structure and market translational research alliances with industry in order to advance promising research projects that have commercial potential. For more information, contact Larry Schlossman [email protected] at 212-746-6909.
About Boehringer Ingelheim in Respiratory
Boehringer Ingelheim has over 90 years of heritage in respiratory disease. Since 1921 the company has emerged as a leader in this disease area and has launched several treatments in a range of respiratory conditions including asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF) and lung cancer. Boehringer Ingelheims focus is on improving the quality of life of patients suffering from debilitating respiratory diseases and enabling them to maintain a more independent life.
About Boehringer Ingelheim Pharmaceuticals, Inc. Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation.
Boehringer Ingelheim is one of the worlds 20 leading pharmaceutical companies.Headquartered in Ingelheim, Germany, the company operates globally with 145affiliates and more than 47,000 employees.Since its founding in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel treatments for human and veterinary medicine.
Boehringer Ingelheim is committed to improving lives and providing valuable services and support to patients and their families. Our employees create and engage in programs that strengthen our communities. To learn more about how we make more health for more people, visit ourCorporate Social Responsibility Report.
In 2015, Boehringer Ingelheim achieved net sales of about $15.8B (14.8billioneuros). R&D expenditure corresponds to 20.3 percent of its net sales.
SOURCE: Boehringer Ingelheim Pharmaceuticals, Inc.
Go here to read the rest:
Boehringer Ingelheim And Weill Cornell Medicine Announce New … – Clinical Leader
- First genetic location found for anorexia nervosa - Medical News Today - May 13th, 2017
- Cancer: The genetic cure in Indiana - WNDU-TV - May 13th, 2017
- Direct-to-consumer genetics a new era in personalized medicine? - The Pharma Letter (registration) - May 10th, 2017
- Direct-to-consumer genetic tests: Great for patients, tough on doctors - Healthcare IT News - May 10th, 2017
- Low vitamin D does not raise risk of asthma or dermatitis, study shows - Medical News Today - May 10th, 2017
- Aevi Genomic Medicine Announces Plans to Initiate Phase 2 Clinical Trial to Confirm Genetic Responders to AEVI-001 ... - Marketwired (press release) - May 10th, 2017
- Medicine for rare genetic eye disease backed for NHS use (From ... - Herald Scotland - May 9th, 2017
- New medicine approved by NHS Scotland for patients with devastating rare genetic disease that causes blindness - The Scottish Sun - May 8th, 2017
- Doctors battle 'torment' of rare undiagnosed illnesses - CNN - May 8th, 2017
- In-depth: Hope for 16-year-old California boy fighting rare genetic disease - WRIC - May 7th, 2017
- Understanding genetic variations in black women could improve ... - ScienceBlog.com (blog) - May 7th, 2017
- Researchers Identify Liver Fibrosis-Causing Protein - Sci-News.com - May 6th, 2017
- Direct-to-consumer genetic tests are a 'turning point' for precision medicine, analysts say - FierceHealthcare - May 6th, 2017
- Understanding genetic variations in black women could improve cancer outcomes - UChicago News - May 6th, 2017
- Genetic Test Could Predict Transplant Success in People with Hep C, Cirrhosis - Healthline - May 6th, 2017
- Genetic Journals | Peer Reviewed | High Impact Articles list - April 28th, 2017
- Sense of smell is a unique product of genes and experience ... - Medical News Today - April 28th, 2017
- Are you a chocaholic? Your genes could be to blame - Medical ... - Medical News Today - April 28th, 2017
- Does the Hype Exceed Reality for Precision Medicine? - [email protected] - April 28th, 2017
- Obesity amplifies genetic risk of nonalcoholic fatty liver disease ... - Science Daily - April 28th, 2017
- Five Weill Cornell Medical Students Win Prestigious Howard Hughes Fellowships - Cornell Chronicle - April 28th, 2017
- Jeffrey Hawkins of Illumina is Elected to the Board of ACMG Foundation for Genetic and Genomic Medicine - PR Newswire (press release) - April 28th, 2017
- Marrying research and medicine: The Next Big (Data) Thing tracks digital health innovations - NEXTpittsburgh - April 16th, 2017
- Study finds genetic basis for drug response in childhood absence ... - National Institutes of Health (press release) - April 16th, 2017
- Precision medicine could revolutionize healthcare in Africa, but obstacles abound - Genetic Literacy Project - April 15th, 2017
- Genetic basis for drug response in childhood absence epilepsy ... - Science Daily - April 15th, 2017
- $3.5 million funds study aimed at applying precision medicine to rare tumor disorder - Washington University School of Medicine in St. Louis - April 15th, 2017
- Potential new treatment for cystic fibrosis uncovered - Medical News Today - April 10th, 2017
- Dr. Kevin Most: Genetics - WGN Radio - April 10th, 2017
- Meningitis Bacteria Adapting to STI Niche, Genetic Analysis Shows - Infection Control Today - April 4th, 2017
- Selfies helping to make advances in medicine - WZZM - April 4th, 2017
- UT researchers map genetic code to determine cancer risk - Toledo Blade - April 4th, 2017
- Genetic Counseling Program Overview - School of Medicine - April 1st, 2017
- Researchers Find New Genetic Links Underlying Progressively Blinding Eye Disease - ScienceBlog.com (blog) - April 1st, 2017
- The weirder side of obesity: genetic forms of obesity are rare yet numerous - CNN - March 30th, 2017
- Genetic Carrier Screening - Hopkins Medicine - March 21st, 2017
- Tame the hype: Is medical genetics plagued by unfilled promises? - Genetic Literacy Project - March 21st, 2017
- Intraday Movers: Myriad Genetics, Inc. (NASDAQ:MYGN) , ICU Medical, Inc. (NASDAQ:ICUI) - NYSE Journal (press release) - March 21st, 2017
- Aevi shares smashed by a trial failure for ADHD genetic subgroup - Endpoints News - March 21st, 2017
- School of Medicine - U of U School of Medicine ... - March 15th, 2017
- Enabling Personlized Medicine for Minority Populations - Technology Networks - March 15th, 2017
- Nobody's business'? 5 Things to Know About Genetic Testing Bill - NBCNews.com - March 15th, 2017
- One in five breast cancer patients could benefit from existing treatment, genetic study reveals - Medical Xpress - March 15th, 2017
- Risk for Anorexia Could Be Genetic: Study - NBC Southern California - March 15th, 2017
- Genes Plus Erratic Sleep May Raise Odds for Obesity - Montana Standard - March 12th, 2017
- The House Bill That Could Sideline Medical Research And Digital Health - Huffington Post - March 12th, 2017
- Bilateral tinnitus is hereditary - Science Daily - March 10th, 2017
- Finding Medicine To Fit Your Genes - Huffington Post - March 10th, 2017
- UAB to Launch Statewide Genetics Initiative for Better Health for All Alabama Residents - Newswise (press release) - March 10th, 2017
- Wilson-Raybould wants Supreme Court advice on genetic non-discrimination bill - Medicine Hat News - March 10th, 2017
- Neanderthal teeth tell tales of diet and medicine - Ars Technica - March 8th, 2017
- Lifestyle choices condition colon and rectal cancer risk more than genetics - Medical Xpress - March 8th, 2017
- Genetic Testing Abused by Patient with Factitious Disorder - Monthly Prescribing Reference (registration) - March 8th, 2017
- Will Sickle Cell Be the Next Disease Genetic Engineering Cures? - Gizmodo - March 3rd, 2017
- UC Merced professor finds genetic triggers related to cancer - Merced Sun-Star - March 3rd, 2017
- Protecting Patients from Genetic Discrimination - The Scientist - March 2nd, 2017
- Awards and Honors Across Weill Cornell Medicine - Cornell Chronicle - March 2nd, 2017
- For precision medicine to work, physicians must incorporate holistic health factors, like belief - Genetic Literacy Project - March 2nd, 2017
- Awards and Honors Across Weill Cornell Medicine | Newsroom ... - Cornell Chronicle - March 2nd, 2017
- This well-known health-tech company has a new name - Nashville Business Journal - March 2nd, 2017
- Justice minister seeks input from premiers on genetic discrimination bill - Medicine Hat News - March 2nd, 2017
- WCM-Q study throws light on genetic medical research - Gulf Times - Gulf Times - February 28th, 2017
- Rare but fatal pediatric brain tumor may be stopped with new molecule - Medical News Today - February 28th, 2017
- It's easy money: Lab offers doctors up to $144000 a year to push dubious genetic tests, employees say - STAT - February 28th, 2017
- Discovery of genetic mutation may boost cancer therapies - Medical Xpress - February 27th, 2017
- WCM-Q study pushes the boundaries of genetic medical research - Al-Bawaba - February 27th, 2017
- BI announces COPD collaboration with Weill Cornell Medicine - Danbury News Times - February 26th, 2017
- Scientists find a striking number of genetic changes can occur early ... - Medical Xpress - February 26th, 2017
- Soon, Medication Will be Custom Tailored to Your Specific Genetics - Futurism - February 26th, 2017
- Clues to relationship between schizophrenia and rheumatoid arthritis - Science Daily - February 26th, 2017
- Personalized medicine may do more to treat rather than prevent chronic diseases - Medical Xpress - February 17th, 2017
- Genetic basis for male baldness identified in large-scale study - Medical News Today - February 17th, 2017
- AP, HHMI collaborate on expanded science, health coverage - New Jersey Herald - February 17th, 2017
- Genetic predictors could improve PSA accuracy - ModernMedicine - February 17th, 2017
- Toxicology Conferences 2017 | Pharmacology Conferences ... - January 23rd, 2017
- Genetic code - Wikipedia - December 25th, 2016
- Center for Genetic Medicine Research - Choose Children's - December 6th, 2016
- Master of Science in Genetic Counseling | Icahn School of ... - November 30th, 2016
- Genetic Medicine - November 12th, 2016
- Medical genetics - Wikipedia - October 27th, 2016
Recommendation and review posted by Guinevere Smith